It is a pharma private limited company based in Uttar Pradesh, Uttar Pradesh, India, established in 1995.
1995 | Uttar Pradesh, Uttar Pradesh, India | ActiveBansal Drugs Private Limited, a active private limited company, was established on 31 March 1995 in Uttar Pradesh, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24231UP1995PTC017799. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Neeru Agarwal (Director), Nishant Raman (Director). Past directors included Rajendra Kumar, Gopal Dass. It holds ₹3.18 Cr open charges and ₹1.17 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Prachi Complexkhair Nagar Meerut, Uttar Pradesh, Uttar Pradesh, 250002.
U24231UP1995PTC017799
017799
31 March 1995
₹1.00 M
₹1.00 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Bansal Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neeru Agarwal | Director | 25 Oct 2022 | Current |
| Nishant Raman | Director | 16 Mar 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Oct 2022 | Past |
| Pramod Abcsdd | Director | 16 Mar 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bansal Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.52% increase. The company also saw a slight improvement in profitability, with a 2.66% increase in profit. The company's net worth moved up by a moderate rise of 3.34%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Bansal Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹31,817,000.00
₹11,700,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Feb 2015 | Others | ₹3.18 Cr | Open |
| 28 Mar 2011 | Indian Overseas Bank | ₹5.00 M | Satisfied |
| 18 Dec 2001 | Union Bank Of India | ₹5.00 M | Satisfied |
| 01 Mar 1996 | Union Bank Of India | ₹1.70 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Bansal Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Bansal Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bansal Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Bansal Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity Bansal Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was completed.
A charge with Others of Rs. 31.82 M registered on 21 Feb 2015 with Charge ID 10569070 was modified on 29 May 2024. was recorded as a recent event.
Neeru Agarwal was appointed as a Director was appointed as a Director on 25 Oct 2022 & has been associated with this company since 3 years 2 months . was recorded as a recent event.
Progress on Nishant Raman was appointed as a Director was appointed as a Director on 16 Mar 2015 & has been associated with this company since 10 years 9 months . was documented.
Progress on A charge registered on 28 Mar 2011 via Charge ID 10280907 with Indian Overseas Bank was fully satisfied on 27 Feb 2015. was documented.
The CIN of Bansal Drugs Private Limited is U24231UP1995PTC017799.
Bansal Drugs Private Limited is headquartered at Prachi Complexkhair Nagar Meerut, Uttar Pradesh, Uttar Pradesh, 250002.
Bansal Drugs Private Limited was incorporated on 31 March 1995.
The current directors of Bansal Drugs Private Limited are
The primary industry of Bansal Drugs Private Limited is Trade.
Bansal Drugs Private Limited is unlisted.
The authorized capital of Bansal Drugs Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Bansal Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX